Literature DB >> 15664121

Cell culture isolation of a transmissible cytotoxicity from a human sample of cerebrospinal fluid.

Marinella Portolani1, Francesca Beretti, Claudio Cermelli, Anna M Bartoletti, Paola Pietrosemoli, Annalisa Bargellini, Anto De Pol, Gian Paolo Rossini.   

Abstract

We investigated a transmissible cytotoxicity isolated in VERO cell cultures from a sample of cerebrospinal fluid (CSF) drawn from a woman with ischemic brain injury. Amorphous aggregates formed by subunities of approximately 11 nm of diameter were detected in ultracentrifugates from partially purified cytotoxic cell preparations in the absence of virion-like particles which might justify the trasmissibility of this cytotoxic activity. Results of chemico-physical studies provided indications on the presence in the CSF of two protease-resistant acidic glycoproteins of about 39 and 27 kDa, respectively. The conformational change of a proteinic molecule may associate with particular properties such as tendency to aggregation, resistance to proteolysis, cytotoxicity. Considering that these same properties are shared by proteins present in the CSF sample under study, a hypothesis to pursue is that the CSF inoculum we isolated contained misfolded proteins formed in vivo following the ischemic injury of brain tissue. As far as the in vitro transmissibility of the cytotoxic activity, this could take place following the reproduction of the alterations of those proteins, independently of the original cause(s) which have fostered their formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15664121     DOI: 10.1016/j.neulet.2004.10.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction.

Authors:  F Beretti; V Cenacchi; M Portolani; A Ardizzoni; E Blasi; C Cermelli
Journal:  Cell Mol Neurobiol       Date:  2007-03-23       Impact factor: 4.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.